BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 792852)

  • 1. New experiences with antilymphocyte globulin in human organ transplantation.
    Largiadér F; Ruckert R
    Postgrad Med J; 1976; 52(5 Suppl):79-81. PubMed ID: 792852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
    Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R
    Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR; Barnes AD; Hall CL
    Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of antilymphocyte globulin in cadaveric transplantation.
    Jakobsen J; Flatmark A; Sodal G; Thorsby E
    Postgrad Med J; 1976; 52(5 Suppl):72-4. PubMed ID: 792850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation.
    Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE
    Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antilymphocyte globulin and renal transplantation.
    Tagnon A
    Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 10. [immunosuppression following kidney transplantation using antilymphocyte globulin followed by treatment with cyclosporin. A prospective study].
    Grundmann R; Wienand P; Holland M; Meider G
    Dtsch Med Wochenschr; 1986 Apr; 111(17):659-64. PubMed ID: 3516619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of rabbit antihuman ALG in cadaver kidney transplantation.
    Davis RC; Glasgow AH; Williams LF; Nabseth DC; Olsson CA; Schmitt GW; Idelson BA; Cooperband SR; Harrington JT; Mannick JA
    Transplant Proc; 1971 Mar; 3(1):766-8. PubMed ID: 4937970
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of sensitization to horse antilymphocyte/thymocyte globulin with recipient age and decreased renal allograft survival rates.
    Filo RS; Book B; Pescovitz MD; Milgrom ML; Leapman SB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):577-80. PubMed ID: 8438421
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function.
    Adams MB; Johnson CP; Roza AM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1606-8. PubMed ID: 2652523
    [No Abstract]   [Full Text] [Related]  

  • 17. Early, low dose rabbit ALG therapy in cadaver kidney transplantation.
    Mannick JA; Nabseth DC; Olsson CA; Davis RC
    Transplant Proc; 1972 Dec; 4(4):497-9. PubMed ID: 4566794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with antilymphocyte globulin in kidney transplants].
    Largiadèr F; Linder E; Scheitlin W; Senning A
    Helv Chir Acta; 1970 Apr; 37(1):34-9. PubMed ID: 4939948
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of rabbit anti-human thymocyte globulin in cadaver kidney transplantation. Preliminary experiences.
    Groth CG; Lundgren G; Ringdén O; Berg B; Grimfors G; Bieber CP
    Scand J Urol Nephrol Suppl; 1981; 64():200-4. PubMed ID: 6755681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of histocompatibility and antilymphocyte globulins in the early development of human renal homotransplantation].
    Van Ypersele de Strihou ; Alexandre GP; Coche E; Sokal G
    J Urol Nephrol (Paris); 1969 Sep; 75(9):608-15. PubMed ID: 4103961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.